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Leukocytosis, thrombocytosis and hypercalcemia 
as a triple paraneoplastic syndrome in a patient with 
squamous cell carcinoma of the renal pelvis
Renal yassÕ hücreli karsinomda multiple pareneoplatik sendrom olarak lökositoz, 
trombositoz ve hiperkalsemi
To the Editor,
Squamous cell carcinoma (SCC) of the renal pelvis 
is a rare malignancy [1]. Paraneoplastic syndromes are 
common; however, multiple paraneoplastic syndromes 
are rarely observed. We describe a case with triple 
paraneoplastic syndrome including hypercalcemia, 
leukocytosis and thrombocytosis as multiple 
hematological paraneoplastic syndromes in a patient 
with renal pelvis SCC. 
A 58-year-old male patient was admitted to clinic 
because of right flank pain, nausea, vomiting, and 
constipation. He underwent a right nephrectomy four 
months before and diagnosis of SCC of the renal 
pelvis was established. Invasion of the renal capsule 
and adipose tissue was seen with negative surgical 
border. On admission, he was clinically deteriorated. 
He had anemia (hemoglobin 9 mg/dl), leukocytosis 
(WBC 57.6 x 109/L) and thrombocytosis (576 x 
109/L). Leukocyte differential count showed 85% 
neutrophil, 20% lymphocyte, 7% monocytes, and 1% 
eosinophil, respectively. Serum creatinine, calcium 
and parathyroid hormone levels were 2.6 g/dl (range: 
0.5-1.2 mg/dl), 14 mg/dl (range: 8.8-10.8 mg/dl) and 
6.47 pg/ml (range: 15-65 pg/ml), respectively. 
Abdominal ultrasound revealed hypoechogenic lesions 
in the left renal region, multiple metastases of the liver. 
Fine needle aspiration from the mass revealed SCC. 
Treatment to correct hypercalcemia was started with 
saline hydration, furosemide and, zoledronate. Thorax 
computerized tomography and bone scan were 
negative for metastasis. Peripheral blood smear, bone 
marrow aspiration and biopsy showed no pathologic 
finding regarding any hematologic disorder, bone 
marrow metastasis or infectious disease. Unfortunately, 
we did not perform leukocyte alkaline phosphatase 
(LAP) stain or analysis of Philadelphia chromosome. 
Cisplatin and etoposide combination regimen was 
administered to the patient. Performance status of the 
patient decreased after two cycles of chemotherapy. 
Objective response was not observed. The patient 
died in four months with progressive disease. 
Hypercalcemia was under control with bisphosphonate 
but hematological findings continued. 
Squamous cell carcinoma of the renal pelvis is  rare 
and accounts for less than 1% of urological malignancies 
[1]. It has poor prognosis with a median survival of 3.5 
months. Coexisting urinary stone and carcinoma ranges 
from 18 to 100% [2]. 
Paraneoplastic syndrome has a very wide spectrum, 
from simple clinical events such as fever to complex 
clinical syndrome. Many different mechanisms may 
play a role in the pathogenesis of paraneoplastic 
syndrome, such as cytokines, hormones, and 
autoimmunity, etc. Hypercalcemia is more common in 
squamous histology than other histopathological 
subtypes [3]. Hypercalcemia has two different 
mechanisms: one is paraneoplastic syndrome and the 
other is involvement of bone. Paraneoplastic 
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related peptide and interleukin-6 [4]. Hematologic paraneoplastic 
syndromes have a wide spectrum, from coagulopathy to 
abnormality of blood cells, granulocyte colony-stimulating factor 
(G-CSF) is a major component of the mechanism in leukocytosis 
[5]. Dukes et al. [6] reported paraneoplastic leukemoid reaction 
as a marker for transitional cell carcinoma recurrence. They 
indicated the role of G-CSF in their case. Thrombocytosis 
can occur by complex multiple mechanisms or thrombopoietin 
which has a major hematologic growth factor effect on 
platelet development map play role.
Combination of paraneoplastic syndromes is a seldom 
clinical feature. Double paraneoplastic syndromes are 
relatively common. Triple or more paraneoplastic syndrome 
is highly interesting. Paraneoplastic syndrome of leukocytosis, 
thrombocytosis and hypercalcemia associated with SCC of 
the skin was reported [7]. There is little published data in the 
literature about paraneoplastic syndrome occurring in renal 
pelvic carcinoma [3]. Hypercalcemia and other hematological 
paraneoplastic syndromes had been reported [8]. A triple 
paraneoplastic syndrome in a patient with renal squamous 
cell carcinoma had been reported by Er et al. previously [9]. 
We describe here in a new patient who had the same 
features including hypercalcemia, leukocytosis and 
thrombocytosis in renal SCC. We were not able to show any 
cytokines-, growth factor-or hormone-associated 
pathogenesis in the clinical management. We conclude that 
many of the factors discussed in the literature, such as 
parathyroid hormone-related peptide and G-CSF, may be 
underlying factors in the pathogenesis in our case. 
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